Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

Bullock R, Graham DI, Swanson S, McCulloch J.

J Cereb Blood Flow Metab. 1994 May;14(3):466-71.

PMID:
8163588
2.

YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.

Takahashi M, Ni JW, Kawasaki-Yatsugi S, Toya T, Yatsugi SI, Shimizu-Sasamata M, Koshiya K, Shishikura JI, Sakamoto S, Yamaguchi T.

J Pharmacol Exp Ther. 1998 Feb;284(2):467-73.

3.

Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.

Mackay KB, Kusumoto K, Graham DI, McCulloch J.

Brain Res. 1993 Aug 6;618(2):213-9.

PMID:
8397047
4.

Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.

Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, Koshiya K, Sakamoto S, Uematsu D, Shimizu-Sasamata M.

J Cereb Blood Flow Metab. 1996 Sep;16(5):959-66.

PMID:
8784240
5.

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.

Bullock R, Graham DI, Chen MH, Lowe D, McCulloch J.

J Cereb Blood Flow Metab. 1990 Sep;10(5):668-74.

PMID:
2166743
6.

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

Ozyurt E, Graham DI, Woodruff GN, McCulloch J.

J Cereb Blood Flow Metab. 1988 Feb;8(1):138-43.

PMID:
2892846
7.

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.

Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J.

J Cereb Blood Flow Metab. 1988 Oct;8(5):757-62.

PMID:
2901425
8.

YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.

Takahashi M, Kohara A, Shishikura J, Kawasaki-Yatsugi S, Ni JW, Yatsugi S, Sakamoto S, Okada M, Shimizu-Sasamata M, Yamaguchi T.

CNS Drug Rev. 2002 Winter;8(4):337-52. Review.

9.
10.

Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats.

Akiho H, Iwai A, Tsukamoto S, Koshiya K, Yamaguchi T.

Neuropharmacology. 1998;37(2):159-68.

PMID:
9680240
11.

Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.

Chen M, Bullock R, Graham DI, Frey P, Lowe D, McCulloch J.

Ann Neurol. 1991 Jul;30(1):62-70.

PMID:
1834008
12.

Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.

Matucz E, Móricz K, Gigler G, Simó A, Barkóczy J, Lévay G, Hársing LG Jr, Szénási G.

Brain Res. 2004 Sep 3;1019(1-2):210-6.

PMID:
15306255
13.

Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.

Miyabe M, Kirsch JR, Nishikawa T, Koehler RC, Traystman RJ.

Crit Care Med. 1997 Jun;25(6):1037-43.

PMID:
9201058
14.

AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.

Yao H, Ibayashi S, Nakane H, Cai H, Uchimura H, Fujishima M.

Brain Res. 1997 Apr 4;753(1):80-5.

PMID:
9125434
15.

Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat.

Bannan PE, Graham DI, Lees KR, McCulloch J.

Brain Res. 1994 Nov 21;664(1-2):271-5.

PMID:
7895041
16.

YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.

Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, Shimizu-Sasamata M, Yamaguchi T.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Nov;358(5):586-91.

PMID:
9840429
17.

Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.

Kawasaki-Yatsugi S, Shimizu-Sasamata M, Yatsugi S, Yamaguchi T.

J Pharm Pharmacol. 1998 Aug;50(8):891-8.

PMID:
9751454
18.

Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.

Umemura K, Shimakura A, Nakashima M.

Brain Res. 1997 Oct 31;773(1-2):61-5.

PMID:
9409705
19.

Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia.

Başkaya MK, Rao AM, Donaldson D, Prasad MR, Dempsey RJ.

Neurosurgery. 1997 Feb;40(2):364-70; discussion 370-1.

PMID:
9007871
20.

Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat.

Park CK, McCulloch J, Kang JK, Choi CR.

Neurosci Lett. 1992 Nov 23;147(1):41-4.

PMID:
1480321

Supplemental Content

Support Center